PDE inhibitors have been increasingly studied, particularly in connection with DEN-induced HCC; these compounds have shown great promise regarding cancer treatment in the last decade (Zheng et al., 2024[110]). The gene discussed is ALDH7A1; the disease is hepatocellular carcinoma.